مقاله

design and development of mucoadhesive acyclovir tablet

چکیده

the purpose of this study was to design and optimize an oral controlled release acyclovir mucoadhesive tablet, in term of its drug release and mucoadhesive strength. a 32 full factorial design was employed to study the effect of independent variables like carbopol-934p and hydroxypropyl methylcellulose k100m, which significantly influence characteristics like swelling index, ex-vivo mucoadhesive strength and in-vitro drug release. tablets were prepared by direct compression and evaluated for mucoadhesive strength and in-vitro dissolution parameters. in all the nine formulations studied, the exponent (n) varied between 0.5266 and 0.7110, showing non-fickian release behavior corresponding to coupled diffusion or polymer relaxation, resulting in a controlled and complete drug release up to 12 h. both these polymers had a significant effect on the mucoadhesive strength of the prepared tablets, measured as the force of detachment against sheep gastric mucosa. besides unraveling the effect of the two factors on the various response variables, this study helped in finding the optimized formulation with excellent mucoadhesive strength and controlled drug release. it can be concluded that by formulating mucoadhesive tablets of acyclovir, its complete release can be ensured prior to absorption window and hence the problem of incomplete drug release and erratic absorption could be solved by increasing the retention of drug in git for a longer duration.

اسناد مشابه

  • Design and Development of Mucoadhesive Acyclovir Tablet

    مقاله۲۰۱۰The Iranian Journal of Pharmaceutical ResearchK Krishnat Mali, R Jacky Dias, S Shamling Sakhare

    The purpose of this study was to design and optimize an oral controlled release acyclovir mucoadhesive tablet, in term of its drug release and mucoadhesive strength. A 32 full factorial design was employed to study the effect of independent variables like Carbopol-934P and hydrox

  • Design and Development of Mucoadhesive Acyclovir Tablet

    مقاله۲۰۱۰Iranian Journal of Pharmaceutical ResearchK Krishnat Mali, R Jacky Dias, S Shamling Sakhare

    The purpose of this study was to design and optimize an oral controlled release acyclovir mucoadhesive tablet, in term of its drug release and mucoadhesive strength. A 32 full factorial design was employed to study the effect of independent variables like Carbopol-934P and hydrox

  • Design, development and in vitro evaluation of sertaconazole mucoadhesive vaginal tablet

    سند علمی۲۰۱۲Anita Patel, Jayvadan Patel

    In present study, mucoadhesive vaginal tablet of sertaconazole was designed using a combination of mucoadhesive polymers like Carbopol 934P, chitosan, carboxymethylcellulose sodium, sodium alginate, methyl cellulose, hydroxypropyl methylcellulose and hydroxypropyl cellulose. Effe

  • Development of an ANN optimized mucoadhesive buccal tablet containing flurbiprofen and lidocaine for dental pain.

    سند علمی۲۰۱۶Acta pharmaceuticaAmjad Hussain, Muhammad Ali Syed, Nasir Abbas, Sana Hanif

    A novel mucoadhesive buccal tablet containing flurbiprofen (FLB) and lidocaine HCl (LID) was prepared to relieve dental pain. Tablet formulations (F1-F9) were prepared using variable quantities of mucoadhesive agents, hydroxypropyl methyl cellulose (HPMC) and sodium alginate (SA)

  • Formulation and in Vitro Evaluation of Losartan Potassium Mucoadhesive Buccal Tablets

    سند علمی۲۰۱۳SELLAPPAN VELMURUGAN

    Objective: The Losartan potassium mucoadhesive buccal tablet were prepared using mucoadhesive polymers such as Carbopol 940P, pectin, sodium CMC, Sodium alginate, HPMC K4M, HPMC K15M and HPMC K100M in alone and in combination as release retarding agent to prolong the drug release

  • Formulation and Characterization of Ciclopirox Olamine Mucoadhesive Effervescent Tablets for Vaginal Delivery

    سند علمی۲۰۱۳M. R. Rachh, B. S. Barot, P. B. Parejiya, P. K. Shelat

    The study was aimed to design and evaluate a new effervescent mucoadhesive vaginal drug delivery system for ciclopirox olamine (CPO), a broad-spectrum antifungal, antibacterial, and anti-inflammatory agent for effective treatment in vaginal candidiosis. Various polymers like Poly